- Home
- ACCD
ACCD
Accolade Inc.
as 02-21-2025 4:00pm EST
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | PLYMOUTH MEETING |
| Market Cap: | 281.1M | IPO Year: | 2020 |
| Target Price: | $6.22 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Hold | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.08 - $11.16 | Next Earning Date: | 01-10-2025 |
| Revenue: | $446,718,000 | Revenue Growth: | 14.99% |
| Revenue Growth (this year): | 14.47% | Revenue Growth (next year): | 12.51% |
Stock Insider Trading Activity of Accolade Inc. (ACCD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Cavanaugh Robert N | ACCD | President | Feb 10 '25 | Sell | $6.89 | 252 | $1,735.02 | 216,559 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Feb 10 '25 | Sell | $6.89 | 221 | $1,521.59 | 301,913 | |
| Cavanaugh Robert N | ACCD | President | Feb 3 '25 | Sell | $6.93 | 557 | $3,857.78 | 216,559 | |
| SINGH RAJEEV | ACCD | Chief Executive Officer | Feb 3 '25 | Sell | $6.93 | 1,170 | $8,103.42 | 822,827 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Feb 3 '25 | Sell | $6.93 | 448 | $3,102.85 | 301,913 | |
| Cavanaugh Robert N | ACCD | President | Jan 16 '25 | Sell | $6.86 | 186 | $1,275.77 | 216,559 | |
| SINGH RAJEEV | ACCD | Chief Executive Officer | Jan 16 '25 | Sell | $6.86 | 309 | $2,119.43 | 822,827 | |
| Barnes Stephen H. | ACCD | Chief Financial Officer | Jan 16 '25 | Sell | $6.86 | 154 | $1,056.29 | 301,913 | |
| Cavanaugh Robert N | ACCD | President | Jan 10 '25 | Sell | $6.88 | 256 | $1,761.02 | 216,559 | |
| SINGH RAJEEV | ACCD | Chief Executive Officer | Jan 10 '25 | Sell | $6.88 | 541 | $3,721.54 | 822,827 |
Latest Accolade Inc. News
ACCD Breaking Stock News: Dive into ACCD Ticker-Specific Updates for Smart Investing
PR Newswire
19 days ago
Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering
Insider Monkey
19 days ago
Why Accolade Inc (ACCD) Is Skyrocketing So Far In 2025
Barrons.com
a month ago
Dell Technologies, Accolade, and More Stocks See Action From Activist Investors
Insider Monkey
a month ago
Is Accolade, Inc. (ACCD) the Hottest Smid-Cap Stock So Far In 2025?
MT Newswires
a month ago
Stephens Downgrades Accolade to Equalweight From Overweight, Trims Price Target to $7.03 From $8
Zacks
a month ago
Accolade (ACCD) Reports Q3 Loss, Lags Revenue Estimates
Associated Press Finance
a month ago
Accolade: Fiscal Q3 Earnings Snapshot
MT Newswires
a month ago
Truist Securities Downgrades Accolade to Hold From Buy
Compare ACCD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ACCD Accolade Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.